Will Contrave Be the Next Big Weight Loss Pill?
July 29, 2010 -- An experimental obesity drug that combines the antidepressantbupropion and the addiction drug naltrexone reduces body weight by 5% or more after one year when combined with healthy diet and regular exercise, according to a new report published online in The Lancet.
If approved, the new drug may be the right choice for dieters who get waylaid by their food cravings because it taps into the brain's craving and reward system in addition to curbing appetite. An FDA advisory panel is slated to review the drug, called Contrave, on Dec. 7. Manufacturer Orexigen Therapeutics, Inc. funded the new study.
In the 56-week study, participants received a high dose of the combination pill, a low dose, or a placebo twice a day. They were also advised to eat a low-calorie diet and engage in regular exercise. Those who took the higher dose of the new pill lost 6.1% of their body weight, while those who received the lower dose shed 5% of their body weight. By contrast, those people in the placebo group lost 1.3% of their body weight.
Fully 34% of people who took the high dose of the drug lost at least 10% of their body weight, compared with 11% who received the placebo.
Contrave Fights Cravings
The new combination pill is different than available weight loss medications in several important ways, says study author Frank L. Greenway, MD, a professor and chief of the outpatient clinic at Pennington Biomedical Research Center of Louisiana State University System in Baton Rouge, in an email.
"Both of the drugs in the combination are used to treat addictive disorders, naltrexone for opioid addiction and bupropion for smoking," he tells WebMD. "The combination of bupropion and naltrexone has been shown to work on both the appetite and the reward centers while other obesity medication has concentrated on the appetite mechanism alone," he says.
It may be "helpful for those people for whom craving interferes with their ability to stay on a diet," he says.
The drug is only effective for as long as people take it, he says. "When people stop taking a drug for a chronic disease like high blood pressure or obesity, the blood pressure or weight return to the levels they were prior to treatment."